CANY
STAA icon

Caxton Associates (New York)’s STAAR Surgical STAA Stock Holding History

Caxton Associates (New York)’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-35,000
Closed -$2.15M – 507
2020
Q2 		$2.15M Buy
+35,000
New +$1.43M 0.19% 56

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RAM
Resona Asset Management Koto-Ku,tokyo, Japan $20.1B AUM 26.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Caxton Associates (New York)'s STAA Position: Q2 2024 in Review

Caxton Associates (New York) sold out of STAAR Surgical (STAA) in Q2 2024, closing a stake of 20,307 shares — an estimated $777K sold.

Caxton Associates (New York) first reported a position in STAA in Q2 2020 and held it in 3 quarters. The position peaked at $1.95M in Q4 2023. 223 funds tracked by Wall St. Rank hold STAA as of Q2 2024.

  • Caxton Associates (New York) reported no remaining STAAR Surgical position as of Q2 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 20,307 STAAR Surgical shares in Q2 2024, an estimated $777K.
  • Caxton Associates (New York) first reported a position in STAAR Surgical in Q2 2020 and held it in 3 quarters.
  • Caxton Associates (New York)'s STAAR Surgical position peaked at $1.95M in Q4 2023.
  • 223 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2024.

Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.